Patents by Inventor Matthieu Delince

Matthieu Delince has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230045791
    Abstract: The invention provides monoclonal antibodies and antigen-binding fragments thereof specific for TNFR2, and methods of using the same to treat cancer or autoimmune disorder, including combination therapy with antagonists of the PD-1/PD-L1 immune checkpoint.
    Type: Application
    Filed: January 5, 2021
    Publication date: February 16, 2023
    Inventors: Shuo Wei, Liang Schweizer, Francisco Adrian, Nicola Arturo Aldo Beltraminelli, Pascaline Mary, Matthieu Delince, Qian Zhang, Jennifer Watkins